Maarouf A. Hoteit

faculty photo
Assistant Professor of Clinical Medicine
Director of Multidisciplinary Liver Tumor Clinic, University of Pennsylvania
Program Director, Liver Transplant Fellowship, University of Pennsylvania
Department: Medicine

Contact information
Hospital of the University of Pennsylvania
Penn Transplant Institute
3400 Spruce Street, 2 Dulles
Philadelphia, PA 19104
Office: 215-615-4679
Fax: 215-662-4835
Education:
BS (Biology)
American University of Beirut, 1996.
MD
American University of Beirut, 2000.
Permanent link
 

Description of Itmat Expertise

My primary interest in is in therapeutic trials in hepatocellular carcinoma

Description of Research Expertise

Liver Cancer
Liver Transplantation

Selected Publications

Bittermann T, Hoteit M A, Abt P L, Forde K A, Goldberg D: Waiting time and explant pathology in transplant recipients with hepatocellular carcinoma: a novel study using national data. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 14(7): 1657-63, July 2014.

Bittermann T, Niu B, Hoteit MA, Goldberg D. : Waitlist priority for hepatocellular carcinoma beyond Milan criteria: a potentially appropriate decision without a structured approach American Journal of Transplantation 14(1): 79-87, January 2014.

Levitsky Josh, Fiel Maria Isabel, Norvell John P, Wang Edward, Watt Kymberly D, Curry Michael P, Tewani Sumeet, McCashland Timothy M, Hoteit Maarouf A, Shaked Abraham, Saab Samuel, Chi Amanda C, Tien Amy, Schiano Thomas D: Risk for immune-mediated graft dysfunction in liver transplant recipients with recurrent HCV infection treated with pegylated interferon. Gastroenterology 142(5): 1132-1139.e1, May 2012.

Chalermrat Bunchorntavakul MD, Maarouf Hoteit MD, K. Rajender Reddy MD : Staging of Hepatocellular carcinoma. Primary Liver Cancer: Surveillance, Diagnosis and Treatment. Reau,N and Poordad,F (eds.). Springer, Page: 161-176, 2012.

Hoteit MA, Kamath PS: Vascular complications of Fibrocystic Liver Diseases. Murray KF, Larson AM, eds. Fibrocystic Diseases of the Liver. Humana Press (eds.). Page: 435-444, March 2010.

Hoteit MA, Sanchez W: A Bright Liver. Clinical Gastroenterology and Hepatology 6(9): xxii, September 2008.

Hoteit MA, Watt KD, Heimbach JK, Charlton MR: Recurrence of non-alcoholic steatohepatitis after transplantation: frequency and outcomes. Oral presentation (# 445765), Digestive Disease Week 2008. May 2008.

Hoteit MA, Ghazale AH, Bain AJ, Rosenberg ES, Easley KA, Anania FA, Rutherford RE: Model for end-stage liver disease score versus Child score in predicting the outcome of surgical procedures in patients with cirrhosis. World Journal of Gastroenterology 14(11): 1774-1780, 2008.

Edge M, Hoteit MA, Patel M, Wang X, Baumgarten D, and Cai Q: Clinical Significance of pancreatic duct dilation on computed tomography: a single duct dilation and double duct dilation. World Journal of Gastroenterology 13(11): 1701-1705, March 2007.

Hoteit MA, Anania FA: Treatment of fibrosis in nonalcoholic fatty liver disease. Current Gastroenterology Reports 9(1): 47-53, 2007.

back to top
Last updated: 11/25/2014
The Trustees of the University of Pennsylvania